Cardiovascular Systems price target raised to $24 from $18 at Benchmark Co.

theflyonthewall.com

Benchmark Co. raised its price target for Cardiovascular Systems to reflect its 2014 estimates and keeps a Buy rating on the stock.

View Comments (0)